171 related articles for article (PubMed ID: 33982545)
21. Germline BAP1 inactivation is preferentially associated with metastatic ocular melanoma and cutaneous-ocular melanoma families.
Njauw CN; Kim I; Piris A; Gabree M; Taylor M; Lane AM; DeAngelis MM; Gragoudas E; Duncan LM; Tsao H
PLoS One; 2012; 7(4):e35295. PubMed ID: 22545102
[TBL] [Abstract][Full Text] [Related]
22. Melanoma Genomics.
Newton-Bishop J; Bishop DT; Harland M
Acta Derm Venereol; 2020 Jun; 100(11):adv00138. PubMed ID: 32346746
[TBL] [Abstract][Full Text] [Related]
23. Targeted next generation sequencing reveals unique mutation profile of primary melanocytic tumors of the central nervous system.
van de Nes J; Gessi M; Sucker A; Möller I; Stiller M; Horn S; Scholz SL; Pischler C; Stadtler N; Schilling B; Zimmer L; Hillen U; Scolyer RA; Buckland ME; Lauriola L; Pietsch T; Waha A; Schadendorf D; Murali R; Griewank KG
J Neurooncol; 2016 May; 127(3):435-44. PubMed ID: 26744134
[TBL] [Abstract][Full Text] [Related]
24. Update in genetic susceptibility in melanoma.
Potrony M; Badenas C; Aguilera P; Puig-Butille JA; Carrera C; Malvehy J; Puig S
Ann Transl Med; 2015 Sep; 3(15):210. PubMed ID: 26488006
[TBL] [Abstract][Full Text] [Related]
25. Clinical, environmental and histological distribution of BRAF, NRAS and TERT promoter mutations among patients with cutaneous melanoma: a retrospective study of 563 patients.
Manrique-Silva E; Rachakonda S; Millán-Esteban D; García-Casado Z; Requena C; Través V; Kumar R; Nagore E
Br J Dermatol; 2021 Mar; 184(3):504-513. PubMed ID: 32506424
[TBL] [Abstract][Full Text] [Related]
26. Tissue-specific significance of BAP1 gene mutation in prognostic prediction and molecular taxonomy among different types of cancer.
Wang XY; Wang Z; Huang JB; Ren XD; Ye D; Zhu WW; Qin LX
Tumour Biol; 2017 Jun; 39(6):1010428317699111. PubMed ID: 28618948
[TBL] [Abstract][Full Text] [Related]
27. Germline BAP1 alterations in familial uveal melanoma.
Rai K; Pilarski R; Boru G; Rehman M; Saqr AH; Massengill JB; Singh A; Marino MJ; Davidorf FH; Cebulla CM; H Abdel-Rahman M
Genes Chromosomes Cancer; 2017 Feb; 56(2):168-174. PubMed ID: 27718540
[TBL] [Abstract][Full Text] [Related]
28. Genetic progression of metastatic melanoma.
Rodolfo M; Daniotti M; Vallacchi V
Cancer Lett; 2004 Oct; 214(2):133-47. PubMed ID: 15363539
[TBL] [Abstract][Full Text] [Related]
29. Distinct sets of genetic alterations in melanoma.
Curtin JA; Fridlyand J; Kageshita T; Patel HN; Busam KJ; Kutzner H; Cho KH; Aiba S; Bröcker EB; LeBoit PE; Pinkel D; Bastian BC
N Engl J Med; 2005 Nov; 353(20):2135-47. PubMed ID: 16291983
[TBL] [Abstract][Full Text] [Related]
30. Prevalence and Preliminary Validation of Screening Criteria to Identify Carriers of Germline BAP1 Mutations.
Zauderer MG; Jayakumaran G; DuBoff M; Zhang L; Francis JH; Abramson DH; Cercek A; Nash GM; Shoushtari A; Chapman P; D'Angelo S; Arnold AG; Siegel B; Fleischut MH; Ni A; Rimner A; Rusch VW; Adusumilli PS; Travis W; Sauter JL; Zehir A; Mandelker D; Ladanyi M; Robson M
J Thorac Oncol; 2019 Nov; 14(11):1989-1994. PubMed ID: 31323388
[TBL] [Abstract][Full Text] [Related]
31. Familial Melanoma: Diagnostic and Management Implications.
Rossi M; Pellegrini C; Cardelli L; Ciciarelli V; Di Nardo L; Fargnoli MC
Dermatol Pract Concept; 2019 Jan; 9(1):10-16. PubMed ID: 30775140
[TBL] [Abstract][Full Text] [Related]
32. A BAP1 mutation in a Danish family predisposes to uveal melanoma and other cancers.
Aoude LG; Wadt K; Bojesen A; Crüger D; Borg A; Trent JM; Brown KM; Gerdes AM; Jönsson G; Hayward NK
PLoS One; 2013; 8(8):e72144. PubMed ID: 23977234
[TBL] [Abstract][Full Text] [Related]
33. Germline BAP1-positive patients: the dilemmas of cancer surveillance and a proposed interdisciplinary consensus monitoring strategy.
Star P; Goodwin A; Kapoor R; Conway RM; Long GV; Scolyer RA; Guitera P
Eur J Cancer; 2018 Mar; 92():48-53. PubMed ID: 29413689
[TBL] [Abstract][Full Text] [Related]
34. Recent advances in cutaneous melanoma: towards a molecular model and targeted treatment.
Read J
Australas J Dermatol; 2013 Aug; 54(3):163-72. PubMed ID: 23330781
[TBL] [Abstract][Full Text] [Related]
35. BAP1 tumor predisposition syndrome case report: pathological and clinical aspects of BAP1-inactivated melanocytic tumors (BIMTs), including dermoscopy and confocal microscopy.
Soares de Sá BC; de Macedo MP; Torrezan GT; Braga JCT; Fidalgo F; Moredo LF; Lellis R; Duprat JP; Carraro DM
BMC Cancer; 2019 Nov; 19(1):1077. PubMed ID: 31706282
[TBL] [Abstract][Full Text] [Related]
36. Malignant melanoma--a genetic overview.
Bloethner S; Scherer D; Drechsel M; Hemminki K; Kumar R
Actas Dermosifiliogr; 2009 Nov; 100 Suppl 1():38-51. PubMed ID: 20096196
[TBL] [Abstract][Full Text] [Related]
37.
Bai X; Kong Y; Chi Z; Sheng X; Cui C; Wang X; Mao L; Tang B; Li S; Lian B; Yan X; Zhou L; Dai J; Guo J; Si L
Clin Cancer Res; 2017 Oct; 23(20):6120-6127. PubMed ID: 28720667
[No Abstract] [Full Text] [Related]
38. Analysis of BAP1 Germline Gene Mutation in Young Uveal Melanoma Patients.
Cebulla CM; Binkley EM; Pilarski R; Massengill JB; Rai K; Liebner DA; Marino MJ; Singh AD; Abdel-Rahman MH
Ophthalmic Genet; 2015 Jun; 36(2):126-31. PubMed ID: 25687217
[TBL] [Abstract][Full Text] [Related]
39. Germline BAP1 mutations predispose to malignant mesothelioma.
Testa JR; Cheung M; Pei J; Below JE; Tan Y; Sementino E; Cox NJ; Dogan AU; Pass HI; Trusa S; Hesdorffer M; Nasu M; Powers A; Rivera Z; Comertpay S; Tanji M; Gaudino G; Yang H; Carbone M
Nat Genet; 2011 Aug; 43(10):1022-5. PubMed ID: 21874000
[TBL] [Abstract][Full Text] [Related]
40. A Large Skin-colored Nodule on the Plantar Foot: A Quiz. Melanoma associated with germline BAP1 mutation.
Rojek NW; Korcheva V; Leachman SA
Acta Derm Venereol; 2017 Nov; 97(10):1265-1266. PubMed ID: 28597019
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
